1. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162
2. Plumb JA, Strathdee G, Sludden J, Kaye SB (2000) Reversal of drug resistance in human tumour xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH gene promoter. Cancer Res 60:6039–6044
3. Marathi UK, Dolan ME (1994) Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin and 1, 3-bis(2-chlroethy)-1-nitrosourea in vitro and in vivo. Biochem Pharmacol 48:2127–2134
4. Scotto KW (2002) Transcriptional regulation of ABC transporters. Oncogene 22:7496–7511
5. Agrawal M, Abraham J, Balis FM et al (2003) Increased 99mTc-sestamibi accumulation in normal liver and drug resistant tumours after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res 9:650–656